F 0656
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Develop and implement a complete care plan that meets all the resident's needs, with timetables and
actions that can be measured.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, record review, and policy review the facility did not ensure Resident #11 had a
physician order and/ or care plan for the use of ankle foot orthosis (AFO) to the bilateral lower extremities
per therapy recommendation. This affected one resident (Resident #11) of one resident (Resident #11)
reviewed for a splinting device. This had the potential to affect two residents (Residents #10 and #11) with
recommendations for a splinting device.
Findings include:
Review of the medical record for Resident #11 revealed an admission date of 07/27/20 with diagnoses
including osteoarthritis, difficulty walking, muscle wasting with atrophy, split foot (birth defect that consists of
missing toes), and major depression.
Review of the quarterly Minimum Data Set (MDS) 3.0 assessment dated [DATE] revealed Resident #11 had
impaired cognition. He was independent with bed mobility, transfers, and locomotion. He required limited
assist of one staff with dressing. He was unable to ambulate.
Review of the November 2022 physician orders revealed there was no physician order for Resident #11 to
have AFO's to his bilateral extremities.
Review of undated comprehensive care plan for Resident #11 revealed there was nothing in the care plan
regarding the use of AFO's.
Review of the Occupational Therapy Discharge summary dated [DATE] and completed by Occupational
Therapist (OT) #642 revealed Resident #11 was discharged from therapy because he was at his highest
practical level. The summary revealed Resident #11 completed his lower extremity dressing with minimal
assist including the use of bilateral AFO's.
Review of the [NAME] Report dated 11/28/22 revealed under the dressing section Resident #11 was
independent with dressing. The [NAME] revealed there was nothing in regard to the use of AFO's to the
bilateral lower extremities.
Observation on 12/04/22 at 9:24 A.M. revealed Resident #11 was sitting in his wheelchair and placed his
right lower leg up onto his bed as he was trying to apply his AFO. Observation revealed he had difficulty
applying the AFO especially with fitting the Velcro strap through the hole. Resident #11's roommate,
Resident #7, observed Resident #11 having difficulty and Resident #7 revealed he usually had to help him
in the morning apply his brace as he had a hard time putting it on. Resident #7
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 8
Event ID:
365748
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365748
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/07/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
White Oak Manor
1926 Ridge Avenue
Warren, OH 44484
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
then proceeded to assist Resident #11 apply his AFO to his right lower leg.
Level of Harm - Minimal harm
or potential for actual harm
Interview on 12/04/22 at 9:26 A.M. with Resident #11 revealed most the time he was able to put his AFO on
himself but at times his hands just did not work as well in the morning specially to apply the Velcro strap. He
revealed his roommate, Resident #7, then assisted in putting it on.
Residents Affected - Few
Interview on 12/05/22 at 10:02 A.M. with Rehabilitation Director #641 revealed Resident #11 had bilateral
AFO's for many years and that he recently received occupational therapy until 11/21/22. She revealed
Resident #11 had a recommendation to complete his lower extremity dressing with minimal assist including
his AFO's. She revealed he needed minimal assistance as at times he had difficulty applying the AFO's due
to arthritis in his hands.
Interview on 12/05/22 at 10:39 A.M. and 11:13 A.M. with Regional Director of Clinical Operations #640
verified Resident #11 did not have a physician order and/ or care plan regarding the use of AFO's. She also
verified they had no documented evidence when his AFO's were applied and/ or checked. She revealed
Resident #11 should have had both a physician order and care plan indicating when he should wear his
AFO's and if he needed assistance with the AFO's being applied as well as documentation that the AFO's
were applied.
Review of the undated facility policy labeled; Use of Splints revealed a resident with limited range of motion
was to receive appropriate treatment and services to prevent further decrease in range of motion. The
policy revealed for residents who based on assessment required the use of a splint, that the splint be
applied in accordance with the written plan of care, monitor for consistent use of the splint, report changes
in condition or problems associated with the splint and update the care pan with new or modified
intervention as needed.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365748
If continuation sheet
Page 2 of 8
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365748
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/07/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
White Oak Manor
1926 Ridge Avenue
Warren, OH 44484
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0804
Ensure food and drink is palatable, attractive, and at a safe and appetizing temperature.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation and interview the facility failed to ensure pureed foods were the correct consistency and served
at an appetizing temperature. This affected two residents (Resident #10 and Resident #19) of 27 residents
who received food from the facility. The facility census was 27.
Residents Affected - Few
Findings include:
Interview and observation on 12/04/22 at 8:57 A.M. with Resident #10 revealed the resident had received a
pureed breakfast tray. Resident #10 did not eat the items provided and indicated they didn't taste good.
Observation of a test tray on 12/05/22 at 12:52 P.M., tested after all residents had been served and were
eating, revealed the pureed Chicken [NAME] was 117 degrees Fahrenheit (F). It had good flavor, was the
correct consistency, but was not hot enough. The pureed rice was 125 degrees F, had good flavor, but was
not a smooth enough consistency for puree. The pureed squash was 147 degrees F. It was hot enough, but
bland and lumpy.
Interview on 12/05/22 at 12:58 P.M. with Corporate Dietitian #639 and Dietary Manager #636 verified the
pureed rice and squash were not the correct consistency for a puree diet, and the temperature of the
pureed chicken was not hot enough.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365748
If continuation sheet
Page 3 of 8
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365748
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/07/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
White Oak Manor
1926 Ridge Avenue
Warren, OH 44484
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Safeguard resident-identifiable information and/or maintain medical records on each resident that are in
accordance with accepted professional standards.
Based on record review, interview, and policy review the facility did not ensure accurate medication
administration records for Residents #8, #21 and #22. This affected three residents (Residents #8, #21 and
#22) of five residents reviewed for unnecessary medications. The facility census was 27.
Findings include:
1. Review of the medical record for Resident #8 revealed an admission date of 02/23/21. Diagnoses
included cerebral ischemia, diabetes mellitus (DM) type 2, schizoaffective disorder bipolar type, chronic
kidney disease stage 3, epilepsy and epileptic syndromes with complex partial seizures, gastroesophageal
reflux disease (GERD), hypertension, hyperlipidemia, major depressive disorder, anxiety disorder, and
delusional disorder.
Review of Resident #8's medication administration record (MAR) for October 2022 revealed the following
medications were not documented as administered:
•
Atorvastatin (medication to treat high cholesterol) 10 milligrams (mg) daily at bedtime for hyperlipidemia
(high cholesterol) on 10/08/22 at hs 2 (from 6:00 P.M. to 10:00 P.M.)
•
Lamotrigine (anticonvulsant) 200 mg daily at bedtime for seizures on 10/08/22 at hs 2
•
Lantus (insulin) 100 units (U) per milliliter (ml), inject 18 U subcutaneously (SQ) at bedtime for DM type 2
on 10/02/22, 10/05/22, 10/08/22, 10/16/22 and 10/30/22 at hs 2
•
Olanzapine (antipsychotic) 5 mg daily at bedtime for schizoaffective disorder bipolar type on 10/08/22 at hs
2
•
Protonix (medication to treat acid reflux and/or heartburn) 40 mg daily in the morning for GERD on
10/01/22, 10/03/22, 10/08/22, 10/17/22, 10/22/22 and 10/31/22 at 4:00 A.M.
•
Carvedilol (medication to treat high blood pressure) 12.5 mg twice daily for hypertension on 10/08/22 at hs
(from 8:00 P.M. to 10:00 P.M)
•
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365748
If continuation sheet
Page 4 of 8
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365748
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/07/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
White Oak Manor
1926 Ridge Avenue
Warren, OH 44484
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Keppra (anticonvulsant) 500 mg twice daily for seizures on 10/08/22 at hs
Level of Harm - Minimal harm
or potential for actual harm
•
Residents Affected - Few
Depakote (anticonvulsant) 250 mg three time daily for seizures on 10/01/22, 10/03/22, 10/08/22, 10/17/22,
10/22/22 and 10/31/22 at noc (from 4:00 A.M. to 6:00 A.M.), and on 10/08/22 at hs
•
Humalog (insulin Lispro) inject per sliding scale SQ before meals and at bedtime for DM type 2 on
10/01/22, 10/03/22, 10/08/22, 10/17/22, 10/22/22 and 10/31/22 at 4:00 A.M., on 10/08/22 at pm, and on
10/02/22, 10/05/22, 10/08/22, 10/16/22 and 10/30/22 at hs
Review of Resident #8's MAR for November 2022 revealed the following medications were not documented
as administered:
•
Lantus (insulin) 100 U/ml, inject 18 U SQ at bedtime for DM type 2 on 11/22/22 at hs 2
•
Protonix 40 mg daily in the morning for GERD on 11/14/22 at 4:00 A.M.
•
Depakote 250 mg three time daily for seizures on 11/14/22 at noc
•
Humalog (insulin Lispro) inject per sliding scale SQ before meals and at bedtime for DM type 2 on 11/13/22
and 11/14/22 at 4:00 A.M., and on 11/22/22 at hs
2. Review of the medical record for Resident #21 revealed an admission date of 08/03/18. Diagnoses
included hyperlipidemia, schizoaffective disorder bipolar type, chronic obstructive pulmonary disease with
acute exacerbation, anxiety disorder, anemia due to intrinsic factor deficiency, and restless and agitation.
Review of Resident #21's MAR for October 2022 revealed the following medications were not documented
as administered:
•
Atorvastatin 20 mg daily at bedtime for hyperlipidemia on 10/02/22, 10/05/22, 10/08/22 and 10/31/22 at hs
2
•
Benztropine (anti-tremor) 1 mg at bedtime for schizoaffective disorder, bipolar type on 10/02/22,
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365748
If continuation sheet
Page 5 of 8
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365748
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/07/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
White Oak Manor
1926 Ridge Avenue
Warren, OH 44484
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
10/05/22, 10/08/22 and 10/31/22 at hs 2
Level of Harm - Minimal harm
or potential for actual harm
•
Residents Affected - Few
Depakote 125 mg, give four tablets daily at bedtime for schizoaffective disorder bipolar type on 10/02/22,
10/05/22, 10/08/22 and 10/31/22 at hs 2
•
Depakote 125 mg, give five tablets daily in the morning for schizoaffective disorder bipolar type on
10/01/22, 10/03/22, 10/07/22, 10/08/22, 10/17/22, 10/22/22 and 10/31/22 at 4:00 A.M.
•
Melatonin (hormone that aids in sleep) 3 mg at bedtime for insomnia on 10/02/22, 10/05/22, 10/08/22 and
10/31/22 at hs 2
•
Docusate sodium (stool softener) 100 mg twice daily for constipation on 10/02/22, 10/05/22, 10/08/22 and
10/31/22 at hs
•
Lasix (diuretic) 20 mg twice daily for edema on 10/01/22, 10/03/22, 10/07/22, 10/08/22, 10/17/22, 10/22/22,
10/30/22 and 10/31/22 at 6:00 A.M.
•
Lactulose solution (laxative and ammonia reducer) 10 grams per 15 ml, give 30 ml three times daily for long
term current drug therapy on 10/01/22, 10/03/22, 10/07/22, 10/08/22, 10/17/22, 10/22/22 and 10/31/22 at
noc, and on 10/02/22, 10/05/22, 10/08/22 and 10/31/22 at hs
Review of Resident #21's MAR for November 2022 revealed the following medications were not
documented as administered:
•
Atorvastatin 20 mg daily at bedtime for mild protein-calorie malnutrition on 11/20/22 hs 2
•
Divalproex (anticonvulsant) 125 mg, give 4 tablets at bedtime for schizoaffective disorder bipolar type on
11/20/22 at hs 2
•
Melatonin 3 mg at bedtime for insomnia on 11/20/22 at hs 2
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365748
If continuation sheet
Page 6 of 8
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365748
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/07/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
White Oak Manor
1926 Ridge Avenue
Warren, OH 44484
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
•
Level of Harm - Minimal harm
or potential for actual harm
Docusate sodium 100 mg twice daily for constipation on 11/20/22 at hs
•
Residents Affected - Few
Divalproex 125 mg, give 5 tablets twice daily for schizoaffective disorder bipolar type on 11/13/22 and
11/14/22 at 6:00 A.M., and on 11/16/22 at 2:00 P.M.
•
Lasix 20 mg twice daily for edema on 11/03/22 at 1:00 P.M., on 11/08/22, 11/13/22 and 11/14/22 at 6:00
A.M., and on 11/16/22 at 2:00 P.M.
•
Lactulose solution 10 grams per 15 ml, give 30 ml three times daily for constipation on 11/14/22 at noc, and
on 11/20/22 at hs
3. Review of the medical record for Resident #22 revealed an admission date of 05/18/21. Diagnoses
included acute kidney failure, obstructive and reflux uropathy, adult failure to thrive, anxiety disorder,
schizoaffective disorder, psychoactive substance dependence, bipolar disorder, heart failure, chronic pain,
hypertension, anemia, encephalopathy, and congestive heart failure.
Review of Resident #22's MAR for October 2022 revealed the following medications were not documented
as administered:
•
Pantoprazole (Protonix) 40 mg daily for indigestion on 10/08/22, 10/17/22, 10/22/22 and 10/31/22 at 4:00
A.M.
•
Benztropine 1 mg twice daily for psychoactive substance dependence on 10/16/22 at hs 2
•
Buprenorphine-naloxone film (narcotic) 8-2 mg, 1 film sublingually twice daily for psychoactive substance
dependence on 10/08/22, 10/13/22, 10/17/22, 10/22/22, 10/30/22 and 10/31/22 at 6:00 A.M., and on
10/05/22 and 10/16/22 at 6:00 P.M.
•
Carvedilol 12.5 mg twice daily for hypertension on 10/16/22 at hs 2
•
Doxycycline (antibiotic) 100 mg every 12 hours for intravenous infiltrate for 10 days on 10/05/22,
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365748
If continuation sheet
Page 7 of 8
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365748
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/07/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
White Oak Manor
1926 Ridge Avenue
Warren, OH 44484
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
10/08/22 and 10/13/22 at 6:00 A.M., and on 10/05/22 at 6:00 P.M.
Level of Harm - Minimal harm
or potential for actual harm
•
Levetiracetam (anticonvulsant) 500 mg twice daily for seizures on 10/16/22 at hs 2
Residents Affected - Few
•
Magnesium oxide (supplement) 400 mg twice daily for supplement on 10/16/22 at hs 2
•
Rifaximin 550 (antibiotic) mg twice daily for encephalopathy at hs 2
•
Hydroxyzine (antihistamine) 25 mg three times daily for anxiety on 10/08/22, 10/17/22, 10/22/22 and
10/31/22 at noc, and on 10/16/22 at hs
Review of Resident #22's MAR for November 2022 revealed the following medications were not
documented as administered:
•
Pantoprazole 40 mg daily for indigestion on 11/14/22 at 4:00 A.M.
•
Buprenorphine-naloxone film 8-2 mg, 1 film sublingually twice daily for psychoactive substance
dependence on 11/13/22 and 11/14/22 at 6:00 A.M.
•
Hydroxyzine 25 mg three times daily for anxiety on 11/14/22 at noc
Interview on 12/06/22 at 1:42 P.M. with the Director of Nursing (DON) verified the above findings for
Residents #8, #21 and #22. The DON confirmed Residents #8, #21 and #22's medications listed above
were not documented after administration as required.
Review of the undated facility medication administration times revealed noc was 4:00 A.M. to 6:00 A.M., hs
was 8:00 P.M. to 10:00 P.M., and hs 2 was 6:00 P.M. to 10:00 P.M.
Review of the undated facility policy, Administering Medications revealed the individual administering a
medication must initial the resident's MAR on the appropriate line after giving each medication and before
administering the next ones.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365748
If continuation sheet
Page 8 of 8